Purpura fulminans: MRSA sepsis compounded by diclofenac
Keywords:Purpura fulminans, diclofenac, MRSA
AbstractPurpura fulminans is a rare, albeit a life-threatening emergency which has been reportedly triggered by infections, congenital disorders of protein C or S deficiencies, as well as drugs. Here we report a case of a previously healthy 17 year old male who developed purpura fulminans after fever, sore throat and then getting injection diclofenac. Blood cultures grew Staph. aureus. This case is the first to report two causative etiologies in a single patient. Key words: purpura fulminans, MRSA, diclofenac.
Contou D, Urbina T, de Prost N. Understanding purpura fulminans in adult patients. Intensive care medicine. 2022 Jan;48(1):106-10.
Perera TB, Murphy-Lavoie HM. Purpura Fulminans. In: StatPearls. StatPearls Publishing, Treasure Island (FL); 2021. PMID: 30422460.
Lowry J, Noel E. A Rare Cause of a Rare Disorder: E. coli-Induced Purpura Fulminans Secondary to Urinary Tract Infection. Case Reports in Critical Care. 2022 Apr 6;2022.
de Villa AR, Charles K, Okonoboh P. A Rare Case of Purpura Fulminans in the Setting of Klebsiella pneumoniae Bacteremia. Cureus. 2022 Mar 7;14(3).
Zhitny VP, Lyons M, Perloff A, Menezes J, Pistorio A, Baynosa R. COVID-19 association with purpura fulminans: report of a life threatening complication in a fully vaccinated patient. Journal of Surgical Case Reports. 2022 Mar;2022(3):rjac095
Tang X, Zhang Z, Yang H, Xiao J, Wen X, Dou Y, Yu J, Hu Y. Clinical and genetic features of Chinese pediatric patients with severe congenital protein C deficiency who first presented with purpura fulminans: A case series study and literature review. Thrombosis research. 2022 Jan 3.
CN K. Neonatal Purpura fulminans due to congenital protein C deficiency: case series. University Journal of Medicine and Medical Specialities. 2021 Sep 26;7(2).
Kosaraju N, Korrapati V, Thomas A, James BR. Adult purpura fulminans associated with non-steroidal anti-inflammatory drug use. J Postgrad Med. 2011 Apr-Jun;57(2):145-6.
Russom M, Fitsum Y, Abraham A, Savage RL. Diclofenac and the Risk of Rhabdomyolysis: Analysis of Publications and the WHO Global Pharmacovigilance Database. Drugs Real World Outcomes. 2021 Sep; 8(3): 263–75.
Alves F, Brites MM, Coutinho I. Purpura Fulminans in a 20-Year-Old Female. Journal of the Portuguese Society of Dermatology and Venereology. 2021 Dec 27;79(4):369-71.